Anti-CD138 monoclonal antibody (indatuximab ravtansine biosimilar)

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMA1014-100uL

  • Size

    100uL

  • Price

    $320

1
Indatuximab Ravtansine (BT-062, nBT062-DM4) is an antibody-drug conjugate (ADC). The antibody part (nBT062) is a hinge-unmodified human IgG4 chimerized antibody based on the murine B-B4 precursor, which binds to the linear epitope between residues 90 to 93 of the CD138 core protein. The ADC is under clinical investigation against mulitple myeloma.
target SDC1
gene id 6382
alias SDC1, Syndecan-1, CD138, SYND1, SDC
reactivity Human
host Chimeric
clonality Monoclonal
clone number BT-062, BT062, nBT062-DM4
iso type IgG4
formulation Purified from cell culture supernatant by affinity chromatography; Kept in PBS (pH 7.4) with 0.1% BSA, 0.1% ProClin 300 and 50% Glycerol
applications Flow Cytometry
dilution Flow Cyt 1:100
shipping With ice packs
storage Store at -20°C for at least 1 year. Avoid multiple freeze-thaw cycles.

PRODUCT

  • SKU

    DMA1014-100uL

  • Size

    100uL

  • Price

    $320

1